Vaccines Archives - Page 37 of 41

KHN’s ‘What the Health?’: The Politics of Science

Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.

Sept. 10, 2020

COVID-19

Most Adults Wary of Taking Any Vaccine Approved Before the Election

About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.

By Jordan Rau

Sept. 10, 2020

COVID-19

With Schools Starting Online, Vaccinations Head for Recess

Traditionally, requirements that kids undergo certain immunizations before attending school have been a critical public health tool. Health officials are scrambling to make sure children don’t fall through the cracks.

By Carmen Heredia Rodriguez

Sept. 8, 2020

As Threat of Valley Fever Grows Beyond the Southwest, Push Is On for Vaccine

Efforts are underway to bring to market a vaccine for valley fever, a fungal infection with COVID-like symptoms that occurs in the deserts of the Southwest. The illness is getting more attention as cases rise and a warming climate threatens to spread it through the West.

By Jim Robbins

Sept. 4, 2020

Underfunded and Under Threat

Health Officials Worry Nation’s Not Ready for COVID-19 Vaccine

As the nation awaits a vaccine to end the pandemic, local health departments say they lack the staff, money, tools ― and a unified plan ― to distribute, administer and track millions of vaccines, most of which will require two doses. Dozens of doctors, nurses and health officials interviewed by KHN and The Associated Press expressed their concern and frustration over federal shortcomings.

By Liz Szabo

Sept. 2, 2020

COVID-19

Fauci Says COVID Vaccine Trials Could End Early If Results Are Overwhelming

The nation’s top infectious disease official is confident that an independent panel will base vaccine approval on science, not politics.

By Liz Szabo

Sept. 1, 2020

KHN & PolitiFact HealthCheck

Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims

Donald Trump accepted his party's nomination to seek reelection for a second term as president in front of a partisan audience that appeared to largely lack masks and opt against social distancing.

Aug. 28, 2020

COVID-19

COVID + Influenza: This Is a Good Year to Get a Flu Shot, Experts Advise

A robust sign-up for flu shots could help head off a nightmare scenario in the coming winter of hospitals stuffed with both COVID-19 patients and those suffering from severe effects of influenza. Plus, no one knows how flu and COVID might interact if a patient got both.

By Julie Appleby and Michelle Andrews

Aug. 28, 2020

COVID-19

LA Hospital Seeks Vaccine Trial Participants Among Its Own High-Risk Patients

Harbor-UCLA Medical Center serves patients who are especially vulnerable to the coronavirus: They are essential workers, have chronic diseases and are members of underrepresented racial and ethnic groups. When the safety-net hospital kicks off enrollment for its COVID-19 vaccine trial Wednesday, it will look to those patients to participate.

By Arthur Allen

Aug. 26, 2020

COVID-19

They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma

Advocates of cheap and widely available vaccines thought the pandemic might change business as usual. They were wrong.

By Jay Hancock

Aug. 25, 2020

COVID-19

Trust, Fear and Solidarity Will Determine the Success of a COVID Vaccine

Polio terrified Americans, and in 1955, when Jonas Salk’s vaccine became available, they snapped it up like candy. Sixty-five years later, COVID is the latest dread virus, but many undercurrents could inhibit its acceptance.

By Arthur Allen

Aug. 17, 2020

COVID-19

With COVID Vaccine Trial, Rural Oregon Clinic Steps Onto World Stage

A small allergy clinic in Medford, Oregon, might seem an unlikely place to recruit hundreds of volunteers to test the Moderna vaccine against COVID-19. But its steward has a record of leading hundreds of clinical trials.

By JoNel Aleccia

Aug. 17, 2020

COVID-19

Test Sites Quickly Attract Thousands for COVID-19 Vaccine Study

People have flooded U.S. testing sites with requests to participate in the pivotal, late-stage clinical trials of the first two COVID-19 vaccine candidates.

By Phil Galewitz and JoNel Aleccia

Aug. 7, 2020

COVID-19

America’s Obesity Epidemic Threatens Effectiveness of Any COVID Vaccine

Vaccines engineered to protect the public from influenza, hepatitis B, tetanus and rabies are less effective for obese people, leaving them more vulnerable to serious illness. As scientists race to develop a COVID-19 vaccine, experts say obesity could prove an impediment — a sobering prospect for a nation in which nearly half of all adults are obese.

By Sarah Varney

Aug. 6, 2020

COVID-19

Fauci Unfazed as Scientists Rely on Unproven Methods to Create COVID Vaccines

Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?

By Liz Szabo

Aug. 3, 2020

Podcast

KHN’s ‘What The Health?’: Republicans in COVID Disarray

President Donald Trump’s sobering view of COVID-19 didn’t last long – this week, he was back to pushing hydroxychloroquine, a drug that has been shown not to work in treating the virus. Meanwhile, Republicans on Capitol Hill are still scrambling to agree among themselves and with the White House on the next coronavirus relief bill, as both a moratorium on evictions and extra unemployment payments expire. And the debate over drug prices, which was going to be one of the biggest health issues of this election year, makes a brief appearance. Alice Miranda Ollstein of Politico, Mary Ellen McIntire of CQ Roll Call and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Markian Hawryluk, who wrote the latest KHN-NPR “Bill of the Month” story about a surprise bill from a surprise surgical assistant.

July 30, 2020

COVID-19

Public Health Experts Fear a Hasty FDA Signoff on Vaccine

The FDA must approve any coronavirus vaccine before it’s widely distributed, but political pressure could cloud the decision.

By Arthur Allen

July 29, 2020

COVID-19

A Coronavirus Vaccine: Where Does It Stand?

Under ordinary circumstances, these phases of vaccine development can take years to complete. But now, during the age of coronavirus, the timeline is being shortened. Here's an inventory of where things stand.

By Louis Jacobson, PolitiFact

July 16, 2020

Shingles Vaccination Rate Soars But Leaves Many Behind

A federal study finds 35% of people 60 and older were vaccinated for shingles by 2018, up from 7% in 2008, but low-income people and those who are Black or Hispanic are far less likely to get vaccinated.

By Phil Galewitz

July 9, 2020